DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Hydrocortisone (Hydrocortisone Topical) - Hypotension - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Hypotension (19)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Hydrocortisone (Hydrocortisone Topical) where reactions include hypotension. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Hydrocortisone side effects in

Reported by a physician from United States on 2012-08-22

Patient:

Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Coagulopathy, Hypoglycaemia, Hypocalcaemia, Hypoxia, Hiccups, Alanine Aminotransferase Abnormal, Pneumonitis, Cough, Pain in Extremity, Hypotension, Hyperglycaemia, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Methotrexate Sodium
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin HCL
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Vancomycin; Posaconazole; Voriconazole; Levofloxacin



Possible Hydrocortisone side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypokalaemia, Blood Bilirubin Abnormal, Hiccups, Pleural Effusion, Hypoxia, Hypocalcaemia, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Decreased Appetite, Pain in Extremity, Hypotension, Hyperglycaemia, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, External Ear Pain, Hypercalcaemia, Haematotoxicity, Hypophosphataemia, Diarrhoea, Dehydration, Hypoalbuminaemia, Lower Gastrointestinal Haemorrhage, Hypertension, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Levofloxacin; Voriconazole; Posaconazole; Vancomycin



Possible Hydrocortisone side effects in

Reported by a physician from United States on 2012-08-16

Patient:

Reactions: Off Label Use, Hypotension, Hypertension

Drug(s) suspected as cause:
Cytarabine
    Dosage: on day 1 or days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: per day divided into 2 doses was given orally for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: on day 15 or days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: per dose on days 1, 4, 8 and 11
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: per dose (2 mg maximum dose) was administered intravenously by push on day 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Dosage: 2500 units/m2/dose was given intramuscularly as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia



Possible Hydrocortisone side effects in

Reported by a physician from United States on 2012-08-14

Patient:

Reactions: Thrombosis, Abdominal Pain, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypoxia, Hypocalcaemia, Hiccups, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Pain in Extremity, Hyperglycaemia, Hypotension, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Neuropathy Peripheral, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Hyponatraemia, Gamma-Glutamyltransferase Abnormal, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Levofloxacin; Vancomycin; Posaconazole; Voriconazole



Possible Hydrocortisone side effects in

Reported by a physician from United Kingdom on 2012-07-17

Patient:

Reactions: Abdominal Pain, Tachycardia, Skin Toxicity, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Dizziness, Oedema, Hallucination, Vomiting, Nausea, Gastrointestinal Toxicity, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Condition Aggravated, Adult T-Cell Lymphoma / Leukaemia, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction

Adverse event resulted in: death

Drug(s) suspected as cause:
Hydrocortisone
    Indication: Adult T-Cell Lymphoma / Leukaemia

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)

Cytarabine
    Indication: Adult T-Cell Lymphoma / Leukaemia

Cyclophosphamide
    Dosage: on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Zenapax
    Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
    Indication: Adult T-Cell Lymphoma / Leukaemia

Vincristine
    Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Prednisolone
    Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia

Methotrexate
    Indication: Adult T-Cell Lymphoma / Leukaemia

Radiotherapy
    Indication: Adult T-Cell Lymphoma / Leukaemia

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Other drugs received by patient: Acyclovir; Thiabendazole; Cotrim; Itraconazole



Possible Hydrocortisone side effects in

Reported by a physician from United Kingdom on 2012-07-10

Patient:

Reactions: Abdominal Pain, Skin Toxicity, Tachycardia, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Oedema, Dizziness, Hallucination, Vomiting, Gastrointestinal Toxicity, Nausea, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Adult T-Cell Lymphoma / Leukaemia, Condition Aggravated, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Prednisolone
    Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia

Cytarabine
    Indication: Adult T-Cell Lymphoma / Leukaemia

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Vincristine
    Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Methotrexate
    Indication: Adult T-Cell Lymphoma / Leukaemia

Zenapax
    Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
    Indication: Adult T-Cell Lymphoma / Leukaemia

Hydrocortisone
    Indication: Adult T-Cell Lymphoma / Leukaemia

Radiotherapy
    Indication: Adult T-Cell Lymphoma / Leukaemia

Other drugs received by patient: Cotrim; Itraconazole; Thiabendazole; Acyclovir



Possible Hydrocortisone side effects in 18 year old male

Reported by a physician from United States on 2012-05-10

Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Hypotension, Hyponatraemia, Acidosis, Capillary Leak Syndrome, Sepsis, Platelet Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Pegaspargase
    Dosage: 2500 iu, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-25
    End date: 2012-03-02

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Vincristine
    Dosage: 2 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Prednisone TAB
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-04

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia

Cytarabine
    Dosage: 70 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-24



Possible Hydrocortisone side effects in 18 year old male

Reported by a consumer/non-health professional from United States on 2012-04-13

Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Hypotension, Hyponatraemia, Acidosis, Capillary Leak Syndrome, Sepsis, Platelet Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: 2 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Prednisone TAB
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-04

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia

Pegaspargase
    Dosage: 2500 iu, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-25
    End date: 2012-03-02

Cytarabine
    Dosage: 70 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-24

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia



Possible Hydrocortisone side effects in 10 year old female

Reported by a physician from United States on 2012-04-05

Patient: 10 year old female, weighing 20.8 kg (45.8 pounds)

Reactions: Abdominal Pain, Headache, Caecitis, Hypokalaemia, Fungaemia, Hypoxia, Rash Pustular, Back Pain, Nausea, Pain in Extremity, Hypotension, Hyponatraemia, Febrile Neutropenia, Hypophosphataemia, Respiratory Tract Infection, Neuralgia, Enterocolitis Infectious

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisone
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-27

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-14

Cytarabine
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Pegaspargase
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-15
    End date: 2011-12-29

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-29

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-17

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29



Possible Hydrocortisone side effects in 18 year old male

Reported by a physician from United States on 2012-04-03

Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)

Reactions: White Blood Cell Count Decreased, Abdominal Pain, Metabolic Acidosis, Clostridium Test Positive, Urine Output Decreased, Hypotension, Hyponatraemia, Capillary Leak Syndrome, Platelet Count Decreased, Septic Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Oncaspar
    Dosage: 2500 iu;x1;iv
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Doxorubicin HCL
    Dosage: 60 mg/m**2;x1;iv
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-24

Velcade
    Dosage: 1.3 mg/m**2; qd; iv
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Vincristine
    Dosage: 1.5 mg/m**2;qd;iv
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Prednisone TAB
    Dosage: 20 mg/m**2;qd;po
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-04

Cytarabine
    Dosage: 70 mg;x1;inth
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: inth
    Indication: Acute Lymphocytic Leukaemia



Possible Hydrocortisone side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-30

Patient: 50 year old female, weighing 43.0 kg (94.6 pounds)

Reactions: Pulmonary Hypertension, Right Ventricular Failure, Hypotension, Cardiac Arrest, Intracardiac Thrombus, Thrombosis in Device

Adverse event resulted in: death

Drug(s) suspected as cause:
Hydrocortisone
    Dosage: 1 gm

Aprotinin
    Dosage: 2000000 kiu, loading dose

Aprotinin
    Dosage: test dose
    Indication: Haemorrhage Prophylaxis

Aprotinin
    Dosage: 500000 kiu/h during procedure

Aprotinin
    Dosage: 2000000 kiu, into cpb circuit

Warfarin Sodium
    Dosage: 2.5 mg, qod

Other drugs received by patient: Aspirin; Enalapril; Levothyroxine Sodium; Dobutamine HCL; Vecuronium Bromide; Heparin; Protamine Sulfate; RED Blood Cells; Digoxin; Midazolam; Fentanyl; Fluoxetine



Possible Hydrocortisone side effects in 18 year old male

Reported by a consumer/non-health professional from United States on 2012-03-13

Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Hypotension, Hyponatraemia, Acidosis, Capillary Leak Syndrome, Sepsis, Platelet Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-24

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Cytarabine
    Dosage: 70 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24

Pegaspargase
    Dosage: 2500 iu, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia

Prednisone TAB
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-04

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia



Possible Hydrocortisone side effects in 10 year old female

Reported by a consumer/non-health professional from United States on 2012-03-09

Patient: 10 year old female, weighing 20.8 kg (45.8 pounds)

Reactions: Abdominal Pain, Confusional State, Lung Infection, Headache, Peripheral Sensory Neuropathy, Caecitis, Hypokalaemia, Fungaemia, Hypoxia, Clostridial Infection, Back Pain, Rash Pustular, Vomiting, Nausea, Pain in Extremity, Lung Neoplasm, Hypotension, Febrile Neutropenia, Pancytopenia, Hyponatraemia, Hypophosphataemia, Diarrhoea, NO Therapeutic Response, Sepsis, Hypophagia, Respiratory Tract Infection, Enterocolitis Infectious, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegaspargase
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-15
    End date: 2011-12-29

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-14

Prednisone
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-27

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-29

Cytarabine
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-17



Possible Hydrocortisone side effects in 10 year old female

Reported by a physician from United States on 2012-01-24

Patient: 10 year old female, weighing 20.8 kg (45.8 pounds)

Reactions: Back Pain, Rash Pustular, Abdominal Pain, Nausea, Pain in Extremity, Hypotension, Hyponatraemia, Febrile Neutropenia, Headache, Peripheral Sensory Neuropathy, Caecitis, Hypokalaemia, Hypophosphataemia, Fungaemia, Hypoxia, Respiratory Tract Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-17

Prednisone TAB
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-27

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-29

Pegaspargase
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-15
    End date: 2011-12-29

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-14

Cytarabine
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29



Possible Hydrocortisone side effects in 10 year old male

Reported by a consumer/non-health professional from United States on 2011-10-31

Patient: 10 year old male, weighing 32.0 kg (70.4 pounds)

Reactions: Nausea, Hypotension, Colitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine Sulfate
    Dosage: last dose on 12aug2011
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Cytarabine
    Dosage: last dose on 29jul2011
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Cyclophosphamide
    Dosage: last dose on 01aug2011
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Dexamethasone
    Dosage: last dose on 18aug2011
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Asparaginase
    Dosage: last dose on 13aug2011 erwinia asparaginase
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Daunorubicin HCL
    Dosage: last dose on 30jul2011
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Methotrexate
    Dosage: last dose on 29jul2011
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Sprycel
    Dosage: last dose on 18aug2011,restr on29aug11
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Hydrocortisone
    Dosage: last dose on 29jul2011
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Other drugs received by patient: Filgrastim



Possible Hydrocortisone side effects in 11 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-10-28

Patient: 11 year old female, weighing 35.0 kg (77.0 pounds)

Reactions: Abdominal Pain, Hepatic Function Abnormal, Hypersensitivity, Pain, Rectal Haemorrhage, Extrasystoles, Coagulopathy, Headache, Skin Hyperpigmentation, Caecitis, Erythema, Multi-Organ Failure, Dyspepsia, Chest Pain, Renal Failure Acute, Heart Rate Abnormal, Anuria, Pain in Extremity, Hypotension, Musculoskeletal Pain, Atrial Fibrillation, Rash, Arrhythmia, Acute Lymphocytic Leukaemia, Mucosal Inflammation, Oral Pain, Respiratory Failure, Rash Erythematous, Heart Rate Increased, Electrocardiogram P Wave Abnormal

Adverse event resulted in: death

Drug(s) suspected as cause:
Evoltra
    Dosage: 48 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-06-17
    End date: 2011-06-21

Dexamethasone
    Dosage: 6 mg, bid
    Administration route: Oral
    Start date: 2011-05-26
    End date: 2011-06-08

Dexamethasone
    Dosage: 6 mg, bid
    Administration route: Oral
    Start date: 2011-06-17
    End date: 2011-06-23

Cytarabine
    Dosage: 30 mg, 1x/w
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-05-11
    End date: 2011-06-08

Methotrexate
    Dosage: 12 mg, 1x/w
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-05-11
    End date: 2011-06-22

Etoposide
    Dosage: 120 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-05-12
    End date: 2011-05-16

PEG-Asparaginase
    Dosage: 1200 iu, q2w
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-05-12
    End date: 2011-05-26

Hydrocortisone
    Dosage: 12.5 mg, 1x/w
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-05-11
    End date: 2011-06-08

Vincristine
    Dosage: 1.7 mg, 1x/w
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-05-12
    End date: 2011-06-02

Cyclophosphamide
    Dosage: 360 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-06-17
    End date: 2011-06-21

Dexamethasone
    Dosage: 6 mg, bid
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-05-12
    End date: 2011-05-18

Etoposide
    Dosage: 120 mg, qd
    Start date: 2011-06-17
    End date: 2011-06-21

Dexamethasone
    Dosage: 6 mg, bid
    Administration route: Oral
    Start date: 2011-07-01
    End date: 2011-07-07

Other drugs received by patient: Allopurinol; Cotrim; Levomepromazine; Piperacillin W; Acetaminophen; Ambisome; Acetaminophen; Allopurinol; Ondansetron; Ciprofloxacin; Levomepromazine; Omeprazole; Ondansetron; Penicillin V; Cotrim; Metronidazole



Possible Hydrocortisone side effects in 10 year old male

Reported by a physician from United States on 2011-10-24

Patient: 10 year old male

Reactions: Hypotension, Colitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Vincristine
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Dexamethasone
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Daunorubicin HCL
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Dasatinib
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Cytarabine
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Asparaginase
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Methotrexate
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Hydrocortisone
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Other drugs received by patient: Filgrastim



Possible Hydrocortisone side effects in 10 year old male

Reported by a physician from United States on 2011-10-18

Patient: 10 year old male

Reactions: Hypotension, Colitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Methotrexate
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia

Cyclophosphamide
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Sprycel
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Asparaginase
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Dexamethasone
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Hydrocortisone
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Daunorubicin HCL
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Vincristine Sulfate
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Other drugs received by patient: Filgrastim



Possible Hydrocortisone side effects in 10 year old male

Reported by a consumer/non-health professional from United States on 2011-10-10

Patient: 10 year old male, weighing 32.0 kg (70.4 pounds)

Reactions: Hypotension, Colitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Hydrocortisone
    Dosage: last dose on 29jul2011
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Daunorubicin HCL
    Dosage: last dose on 30jul2011
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Vincristine Sulfate
    Dosage: last dose on 12aug2011
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Cyclophosphamide
    Dosage: last dose on 01aug2011
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Cytarabine
    Dosage: last dose on 29jul2011
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Dexamethasone
    Dosage: last dose on 18aug2011
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Asparaginase
    Dosage: last dose on 18aug2011 erwinia asparaginase
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Methotrexate
    Dosage: last dose on 29jul2011
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Sprycel
    Dosage: last dose on 18aug2011
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-05-26

Other drugs received by patient: Filgrastim

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017